Quantum Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Buy
4,902
+2
+0% +$115 0.03% 185
2026
Q1
$297K Buy
4,900
+528
+12% +$30.8K 0.03% 165
2025
Q4
$236K Buy
+4,372
New +$210K 0.03% 184
2025
Q2
Sell
-3,753
Closed -$229K 183
2025
Q1
$229K Sell
3,753
-1,430
-28% -$83.4K 0.03% 157
2024
Q4
$293K Buy
+5,183
New +$290K 0.04% 129
2023
Q1
Sell
-2,818
Closed -$203K 95
2022
Q4
$203K Buy
+2,818
New +$212K 0.09% 88

Other funds holding BMY

Quantum Financial Advisors's BMY Position: Q2 2026 in Review

Quantum Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.04% in Q2 2026, buying an estimated $115 and bringing the position to 4,902 shares worth $282K. The position accounts for 0.03% of the portfolio, ranked #185.

Quantum Financial Advisors first reported a position in BMY in Q4 2022 and has held it in 6 quarters since. The position peaked at $297K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Quantum Financial Advisors held 4,902 shares of Bristol-Myers Squibb worth $282K as of Q2 2026.
  • Quantum Financial Advisors bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
  • Bristol-Myers Squibb made up 0.03% of Quantum Financial Advisors's portfolio in Q2 2026, its #185 holding.
  • Quantum Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 6 quarters since.
  • Quantum Financial Advisors's Bristol-Myers Squibb position peaked at $297K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.